Xilio Therapeutics Inc (XLO) Stock Price, Quote, News & History

XLONASDAQ
$9.01
-0.04-0.44%
At close: Aug 13, 5:00 PM EST
$9.08
0.070.78%
After Hours: 7:39 AM EST
Earnings: Q2 2026 Earnings were released on Wed Aug 12th, before the market open

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-60.60M
Investing Cash Flow (TTM)
-670.00K
Financing Cash Flow (TTM)
75.78M
Free Cash Flow (TTM)
-61.27M
Capital Expenditure (TTM)
-670.00K
Net Change in Cash (TTM)
14.51M

Analyst Rating and Forecast

12345
4.7
Strong Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$70.52M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.00
PB Ratio (TTM)
0.82
Earnings Yield % (TTM)
-3.56%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$10.98

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$136.04M
Debt to Equity
0.09
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.05
Close
$9.01
Volume / Avg.
13.38K / 46.35K
Day Range
$8.90 - $9.28
52 Wk Range
6.47 - 12.74
Market Cap
$59.75M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
49
Short Interest
7.23%
Days to Cover
12.28

About

Sector
Health Care
Industry
Biotechnology
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology an...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Xilio Therapeutics (XLO) stock?

A

You can purchase shares of Xilio Therapeutics (NASDAQ:XLO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Xilio Therapeutics (XLO) competitors?

Q

What is the forecast, or price target, for Xilio Therapeutics (XLO) stock?

A

Xilio Therapeutics has a consensus price target of $3.00.

Q

What is the current price for Xilio Therapeutics (XLO)?

A

The stock price for Xilio Therapeutics (NASDAQ: XLO) is $9.08 last updated August 13, 2026 at 7:39 AM EDT.

Q

Does Xilio Therapeutics (XLO) pay a dividend?

A

There are no upcoming dividends for Xilio Therapeutics.

Q

When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?

A

Xilio Therapeutics does not have any upcoming earnings scheduled.

Q

Is Xilio Therapeutics (XLO) going to split?

A

There is no upcoming split for Xilio Therapeutics.

Q

What sector and industry does Xilio Therapeutics (XLO) operate in?

A

Xilio Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.